Ruhnn to Participate in Citi Pan-Asia Regional Investor Conference

HANGZHOU, China, May 12, 2020 (GLOBE NEWSWIRE) -- Ruhnn Holding Limited (“Ruhnn” or the “Company”) (NASDAQ: RUHN), a leading internet key opinion leader (“KOL”) facilitator in China, today announced its participation in Citi Pan-Asia Regional Investor Conference. The conference, which will take place on May 19-21, 2020, will be conducted with a virtual format.

The Company’s management will participate in virtual meetings with institutional investors. For additional information, please contact your Citi representative.

About Ruhnn Holding Limited

Ruhnn Holding Limited is a leading internet KOL facilitator in China. The Company connects influential KOLs who engage and impact their fans on the internet to its vast commercial network to build the brands of fashion products. Ruhnn pioneered the commercialization of the KOL ecosystem in China, and operates under both full-service and platform models. The Company’s full-service model integrates key steps of the e-commerce value chain from product design and sourcing and online store operations to logistics and after-sale services. The platform model promotes products sold in third-party online stores and provides advertising services on KOL’s social media spaces to third-party merchants. As of December 31, 2019, the Company had 159 signed KOLs with an aggregate of 201.5 million fans across major social media platforms in China.

For more information, please visit: ir.ruhnn.com.

For investor and media inquiries, please contact:

In China:

Ruhnn Holding LimitedSterling SongSenior Director of Investor RelationsTel: +86-571-2825-6700E-mail: [email protected]

The Piacente Group, Inc.Emilie WuTel: +86-21-6039-8363E-mail: [email protected]

In the United States:

The Piacente Group, Inc.Brandi PiacenteTel: +1-212-481-2050E-mail: [email protected]

Source: Ruhnn Holdings Limited

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• Crypto News: Hyperliquid, TRUMP Memecoin, and MemeToro Shape the 2026 Altcoin Market
• CorelDRAW 2026 Review: New Features and Workflow Updates for Designers and Print Professionals Highlighted by Expert Consumers